BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29240080)

  • 1. Reinterpretation of sequence variants: one diagnostic laboratory's experience, and the need for standard guidelines.
    Chisholm C; Daoud H; Ghani M; Mettler G; McGowan-Jordan J; Sinclair-Bourque L; Smith A; Jarinova O
    Genet Med; 2018 Mar; 20(3):365-368. PubMed ID: 29240080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically impactful differences in variant interpretation between clinicians and testing laboratories: a single-center experience.
    Bland A; Harrington EA; Dunn K; Pariani M; Platt JCK; Grove ME; Caleshu C
    Genet Med; 2018 Mar; 20(3):369-373. PubMed ID: 29240077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reinterpretation, reclassification, and its downstream effects: challenges for clinical laboratory geneticists.
    El Mecky J; Johansson L; Plantinga M; Fenwick A; Lucassen A; Dijkhuizen T; van der Hout A; Lyle K; van Langen I
    BMC Med Genomics; 2019 Nov; 12(1):170. PubMed ID: 31779608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
    Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
    Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reclassification of clinically-detected sequence variants: Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK).
    Loong L; Garrett A; Allen S; Choi S; Durkie M; Callaway A; Drummond J; Burghel GJ; Robinson R; Torr B; Berry IR; Wallace AJ; Eccles DM; Ellard S; Baple E; Evans DG; Woodward ER; Kulkarni A; Lalloo F; Tischkowitz M; Lucassen A; Hanson H; Turnbull C;
    Genet Med; 2022 Sep; 24(9):1867-1877. PubMed ID: 35657381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges of variant reinterpretation: Opinions of stakeholders and need for guidelines.
    Berger SM; Appelbaum PS; Siegel K; Wynn J; Saami AM; Brokamp E; O'Connor BC; Hamid R; Martin DM; Chung WK
    Genet Med; 2022 Sep; 24(9):1878-1887. PubMed ID: 35767006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility and Outcomes of the 2019 American College of Medical Genetics and Genomics-Clinical Genome Resource Guidelines for Interpretation of Copy Number Variants with Borderline Classifications at an Academic Clinical Diagnostic Laboratory.
    Drackley A; Brew C; Wlodaver A; Spencer S; Leuer K; Rathbun P; Charrow J; Wieneke X; Yap KL; Ing A
    J Mol Diagn; 2022 Oct; 24(10):1100-1111. PubMed ID: 35868509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer.
    Sirohi D; Schmidt RL; Aisner DL; Behdad A; Betz BL; Brown N; Coleman JF; Corless CL; Deftereos G; Ewalt MD; Fernandes H; Hsiao SJ; Mansukhani MM; Murray SS; Niu N; Ritterhouse LL; Suarez CJ; Tafe LJ; Thorson JA; Segal JP; Furtado LV
    J Mol Diagn; 2020 Feb; 22(2):284-293. PubMed ID: 31837433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data sharing to improve concordance in variant interpretation across laboratories: results from the Canadian Open Genetics Repository.
    Mighton C; Smith AC; Mayers J; Tomaszewski R; Taylor S; Hume S; Agatep R; Spriggs E; Feilotter HE; Semenuk L; Wong H; Lazo de la Vega L; Marshall CR; Axford MM; Silver T; Charames GS; Di Gioacchino V; Watkins N; Foulkes WD; Clavier M; Hamel N; Chong G; Lamont RE; Parboosingh J; Karsan A; Bosdet I; Young SS; Tucker T; Akbari MR; Speevak MD; Vaags AK; Lebo MS; Lerner-Ellis J;
    J Med Genet; 2022 Jun; 59(6):571-578. PubMed ID: 33875564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCMG practice guideline: laboratory guidelines for next-generation sequencing.
    Hume S; Nelson TN; Speevak M; McCready E; Agatep R; Feilotter H; Parboosingh J; Stavropoulos DJ; Taylor S; Stockley TL;
    J Med Genet; 2019 Dec; 56(12):792-800. PubMed ID: 31300550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy number variants.
    Brandt T; Sack LM; Arjona D; Tan D; Mei H; Cui H; Gao H; Bean LJH; Ankala A; Del Gaudio D; Knight Johnson A; Vincent LM; Reavey C; Lai A; Richard G; Meck JM
    Genet Med; 2020 Feb; 22(2):336-344. PubMed ID: 31534211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of VUS reporting, variant reinterpretation and recontact policies in clinical genomic sequencing consent forms.
    Vears DF; Niemiec E; Howard HC; Borry P
    Eur J Hum Genet; 2018 Dec; 26(12):1743-1751. PubMed ID: 30143804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Utility of Reinterpreting Previously Reported Genomic Epilepsy Test Results for Pediatric Patients.
    SoRelle JA; Thodeson DM; Arnold S; Gotway G; Park JY
    JAMA Pediatr; 2019 Jan; 173(1):e182302. PubMed ID: 30398534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Somatic Curation and Interpretation Across Laboratories (SOCIAL) project-current state of solid-tumour variant interpretation for molecular pathology in Canada.
    Spence T; Sukhai MA; Kamel-Reid S; Stockley TL
    Curr Oncol; 2019 Dec; 26(6):353-360. PubMed ID: 31896933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data sharing as a national quality improvement program: reporting on BRCA1 and BRCA2 variant-interpretation comparisons through the Canadian Open Genetics Repository (COGR).
    Lebo MS; Zakoor KR; Chun K; Speevak MD; Waye JS; McCready E; Parboosingh JS; Lamont RE; Feilotter H; Bosdet I; Tucker T; Young S; Karsan A; Charames GS; Agatep R; Spriggs EL; Chisholm C; Vasli N; Daoud H; Jarinova O; Tomaszewski R; Hume S; Taylor S; Akbari MR; Lerner-Ellis J;
    Genet Med; 2018 Mar; 20(3):294-302. PubMed ID: 28726806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant Reinterpretation in Survivors of Cardiac Arrest With Preserved Ejection Fraction (the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry) by Clinicians and Clinical Commercial Laboratories.
    Davies B; Bartels K; Hathaway J; Xu F; Roberts JD; Tadros R; Green MS; Healey JS; Simpson CS; Sanatani S; Steinberg C; Gardner M; Angaran P; Talajic M; Hamilton R; Arbour L; Seifer C; Fournier A; Joza J; Krahn AD; Lehman A; Laksman ZWM
    Circ Genom Precis Med; 2021 Jun; 14(3):e003235. PubMed ID: 33960826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
    BalmaƱa J; Digiovanni L; Gaddam P; Walsh MF; Joseph V; Stadler ZK; Nathanson KL; Garber JE; Couch FJ; Offit K; Robson ME; Domchek SM
    J Clin Oncol; 2016 Dec; 34(34):4071-4078. PubMed ID: 27621404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for laboratory workflow that better support centralised amalgamation of genomic variant data: findings from CanVIG-UK national molecular laboratory survey.
    Allen S; Loong L; Garrett A; Torr B; Durkie M; Drummond J; Callaway A; Robinson R; Burghel GJ; Hanson H; Field J; McDevitt T; McVeigh TP; Bedenham T; Bowles C; Bradshaw K; Brooks C; Butler S; Del Rey Jimenez JC; Hawkes L; Stinton V; MacMahon S; Owens M; Palmer-Smith S; Smith K; Tellez J; Valganon-Petrizan M; Waskiewicz E; Yau M; Eccles DM; Tischkowitz M; Goel S; McRonald F; Antoniou AC; Morris E; Hardy S; Turnbull C
    J Med Genet; 2024 Mar; 61(4):305-312. PubMed ID: 38154813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies.
    Amendola LM; Muenzen K; Biesecker LG; Bowling KM; Cooper GM; Dorschner MO; Driscoll C; Foreman AKM; Golden-Grant K; Greally JM; Hindorff L; Kanavy D; Jobanputra V; Johnston JJ; Kenny EE; McNulty S; Murali P; Ou J; Powell BC; Rehm HL; Rolf B; Roman TS; Van Ziffle J; Guha S; Abhyankar A; Crosslin D; Venner E; Yuan B; Zouk H; ; Jarvik GP
    Am J Hum Genet; 2020 Nov; 107(5):932-941. PubMed ID: 33108757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome analysis and knowledge-driven variant interpretation with TGex.
    Dahary D; Golan Y; Mazor Y; Zelig O; Barshir R; Twik M; Iny Stein T; Rosner G; Kariv R; Chen F; Zhang Q; Shen Y; Safran M; Lancet D; Fishilevich S
    BMC Med Genomics; 2019 Dec; 12(1):200. PubMed ID: 31888639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.